vancomycin has been researched along with indomethacin in 22 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (4.55) | 18.7374 |
1990's | 3 (13.64) | 18.2507 |
2000's | 5 (22.73) | 29.6817 |
2010's | 12 (54.55) | 24.3611 |
2020's | 1 (4.55) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Abraham, R; Basavarajaswamy, G; Giles, D; Mathew, V; Sandhya, B | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Andersen, RJ; Laphookhieo, S; Maneerat, W; Pyne, SG; Raksat, A; Rujanapun, N | 1 |
Gal, P; Spivey, JM | 1 |
Altirriba Valls, O; Demestre Guasch, X; Farré Riba, R; Ginovart Galiana, G; Lopes Santos, AP; Mangues Bafalluy, MA | 1 |
Almeida, AM; Bispo, MA; Costa, IM; Falcão, AC; Falcão, F; Palminha, JM; Reis, E; Silva, R | 1 |
Perman, E | 1 |
Allegaert, K; Anderson, BJ; Rayyan, M | 1 |
Ewald, U; Friberg, LE; Honoré, PH; Nielsen, EI; Sandström, M | 1 |
Allegaert, K | 1 |
Bernstein, HM; Dickinson, GM; Hunte, TC | 1 |
Hamaguchi, T; Horibe, S; Inoue, J; Kawauchi, S; Miki, I; Mizuno, S; Nakamura, T; Nishikawa, C; Tanahashi, T; Yasui, H | 1 |
Allegaert, K; Cristea, S; Falcao, AC; Falcao, F; Knibbe, CAJ; Krekels, EHJ; Silva, R; Smits, A | 1 |
Dhaliwal, JS; Dhaliwal, SKS; Goh, HP; Goh, KW; Hermansyah, A; Hossain, MS; Kifli, N; Kotra, V; Loy, MJ; Ming, LC; Moshawih, S; Yassin, H | 1 |
2 review(s) available for vancomycin and indomethacin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Pharmacotherapeutics Applications and Chemistry of Chalcone Derivatives.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Antimalarials; Chalcone; Chalcones; Indomethacin; Lipoxygenases; Pharmaceutical Preparations; Structure-Activity Relationship; Tetracyclines; Vancomycin | 2022 |
2 trial(s) available for vancomycin and indomethacin
Article | Year |
---|---|
Impact of ibuprofen administration on renal drug clearance in the first weeks of life.
Topics: Age Factors; Amikacin; Anti-Bacterial Agents; Aspirin; Betamethasone; Birth Weight; Cyclooxygenase Inhibitors; Double-Blind Method; Ductus Arteriosus, Patent; Female; Glomerular Filtration Rate; Humans; Ibuprofen; Indomethacin; Infant, Newborn; Infant, Premature; Infusions, Intravenous; Kidney; Metabolic Clearance Rate; Postmenopause; Pregnancy; Time Factors; Vancomycin | 2006 |
Developmental pharmacokinetics of gentamicin in preterm and term neonates: population modelling of a prospective study.
Topics: Age Factors; Biomarkers; Body Weight; Cefuroxime; Creatinine; Cystatin C; Drug Interactions; Female; Gentamicins; Gestational Age; Humans; Indomethacin; Infant; Infant, Newborn; Infant, Premature; Male; Nonlinear Dynamics; Vancomycin | 2009 |
18 other study(ies) available for vancomycin and indomethacin
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Synthesis, pharmacological evaluation and docking studies of coumarin derivatives.
Topics: Animals; Coumarins; Magnetic Resonance Spectroscopy; Male; Models, Molecular; Rats; Rats, Wistar; Spectrophotometry, Infrared | 2011 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Antibacterial and Inhibitory Activities against Nitric Oxide Production of Coumaronochromones and Prenylated Isoflavones from
Topics: Animals; Anti-Bacterial Agents; Chromones; Isoflavones; Mice; Microbial Sensitivity Tests; Millettia; Nitric Oxide; Prenylation; RAW 264.7 Cells | 2019 |
Vancomycin pharmacokinetics in neonates.
Topics: Drug Interactions; Ductus Arteriosus, Patent; Half-Life; Humans; Indomethacin; Infant, Newborn; Kinetics; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 1986 |
[Pharmacokinetics of vancomycin in neonates of postconceptional age less than or equal to 32 weeks].
Topics: Anti-Bacterial Agents; Creatinine; Dose-Response Relationship, Drug; Gestational Age; Humans; Indomethacin; Infant, Newborn; Infant, Premature; Respiration, Artificial; Staphylococcal Infections; Vancomycin | 1996 |
The kinetic profile of vancomycin in neonates.
Topics: Body Weight; Critical Care; Drug Interactions; Female; Gram-Positive Bacterial Infections; Guidelines as Topic; Humans; Indomethacin; Infant; Infant, Newborn; Injections, Intravenous; Male; Metabolic Clearance Rate; Regression Analysis; Retrospective Studies; Tissue Distribution; Vancomycin | 1998 |
["Sudden deafness" has not been classified as a side-effect. No compensation from the Drug Insurance Authority].
Topics: Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Female; Hearing Loss; Hearing Loss, Sudden; Humans; Indomethacin; Insurance Claim Review; Male; Middle Aged; Vancomycin | 1999 |
The impact of ibuprofen or indomethacin on renal drug clearance in neonates.
Topics: Amikacin; Anti-Bacterial Agents; Cyclooxygenase Inhibitors; Drug Interactions; Glomerular Filtration Rate; Humans; Ibuprofen; Indomethacin; Infant, Newborn; Kidney; Metabolic Clearance Rate; Vancomycin | 2009 |
Acute crystalline arthritis in an artificial knee.
Topics: Acute Disease; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthroplasty, Replacement, Knee; Calcium Pyrophosphate; Chondrocalcinosis; Debridement; Humans; Indomethacin; Inflammation; Male; Middle Aged; Pneumonia; Postoperative Complications; Synovial Fluid; Vancomycin | 2012 |
Intestinal and hepatic expression of cytochrome P450s and mdr1a in rats with indomethacin-induced small intestinal ulcers.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aryl Hydrocarbon Hydroxylases; ATP Binding Cassette Transporter, Subfamily B; Cytochrome P-450 CYP2E1; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 2; Disease Models, Animal; Gene Expression; Hep G2 Cells; Humans; Indomethacin; Intestinal Diseases; Intestine, Small; Liver; Male; Rats; Rats, Sprague-Dawley; RNA, Messenger; Steroid 16-alpha-Hydroxylase; Ulcer; Vancomycin | 2014 |
Larger Dose Reductions of Vancomycin Required in Neonates with Patent Ductus Arteriosus Receiving Indomethacin versus Ibuprofen.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Ductus Arteriosus, Patent; Female; Humans; Ibuprofen; Indomethacin; Infant, Newborn; Male; Monte Carlo Method; Pregnancy; Vancomycin; Young Adult | 2019 |